- May 28, 2018
- Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical to Launch Tiovita Drink Aibitasu Zero Nationwide on May 28, 2018 "No fatigue the next day!"
Taiho Pharmaceutical Co., Ltd. announced today that it has launched Tiovita Drink Aibitasu Zero ( third-class OTC drug), the first caffeine-free, sugar-free product in the Tiovita series, throughout Japan on Monday, May 28, 2018.
The new product retains the features of the original Tiovita Drink Aibitasu* but without the caffeine and sugar, resulting in a low calorie product at only 7 kcal per bottle. As the first caffeine-free product in the Tiovita series, Tiovita Drink Aibitasu Zero is a nutritious drink that can be enjoyed before bedtime.
Taiho Pharmaceutical is determined to keep contributing to healthy living by providing Tiovita series products.
*Tiovita Drink Aibitasu has a smooth blueberry flavor and contains 1,000 mg of taurine and more Vitamin B1, B2, and B6 than Tiovita Drink (a designated quasi-drug).
Features of Tiovita Drink Aibitasu Zero
- First caffeine-free, sugar-free product in the Tiovita series
- Low calories: 7 kcal per bottle
- 1,000 mg of taurine, which is an active ingredient, and more Vitamin B1, B2, and B6 compared to Tiovita Drink (a designated quasi-drug)
- Smooth blueberry flavor
Product Overview
| Brand name | Tiovita Drink Aibitasu Zero |
|---|---|
| Risk categories | Third-class OTC drug |
| Suggested retail price | 180 yen (excl. tax) per bottle |
| Ingredients | Per 100 mL bottle Taurine 1000 mg Inositol 50 mg Niacinamide 20mg Thiamine nitrate (Vitamin B1) 10 mg Riboflavin sodium phosphate (Vitamin B2) 15 mg Pyridoxine hydrochloride (Vitamin B6) 50 mg Carnitine chloride 120 mg |
| Indications | ・Nutritional fortification ・Weak constitution improvement ・Nutritional support for physical exhaustion, during and after illness, loss of appetite, malnutrition, febrile debilitating illness, before and after childbirth, etc. |
| Dosage and administration | For adults (15 years and older): 1 bottle (100 mL) per day |
| Launch date | Nationwide on Monday, May 28, 2018 |
Information in this news release was current as of the original release date.
Taiho Pharmaceutical's news releases are intended to provide information to the media. It may contain information about ethical drugs or products under development, however information contained in the news releases are not intended to constitute promotion, advertisement, or medical advice.